Requirement of the orphan nuclear receptor SF-1 in terminal differentiation of ventromedial hypothalamic neurons

Molecular and Cellular Neuroscience

Volumn 22, Issue 4, 2003, Pages 441-453

  Tran, Phu V ^a   Lee, Martin B ^a   Marín, Oscar ^a   Xu, Baoji ^a   Jones, Kevin R ^b   Reichardt, Louis F ^a   Rubenstein, John R ^a   Ingraham, Holly A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL NUCLEUS RECEPTOR; STEROIDOGENIC FACTOR 1;

AGENESIS; AMYGDALOID NUCLEUS; ANIMAL CELL; APOPTOSIS; ARTICLE; CELL MATURATION; CONTROLLED STUDY; ENDOCRINE GLAND; FEEDING; HYPOTHALAMUS; HYPOTHALAMUS VENTROMEDIAL NUCLEUS; MOLECULAR BIOLOGY; MOUSE; MOUSE STRAIN; NERVE CELL DIFFERENTIATION; NONHUMAN; ORGANOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SEXUAL BEHAVIOR; STRIA TERMINALIS; TELENCEPHALON;

TERMINALIS;

EID: 0037398246     PISSN: 10447431     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1044-7431(03)00027-7     Document Type: Article

References (60)

1. Achermann J.C., Ito M., Hindmarsh P.C., Jameson J.L. A mutation in the gene encoding steroidogenic factor-1 causes XY sex reversal and adrenal failure in humans. Nat. Genet. 22:1999;125-126.
2. Achermann J.C., Ozisik G., Ito M., Orun U.A., Harmanci K., Gurakan B., Jameson J.L. Gonadal determination and adrenal development are regulated by the orphan nuclear receptor steroidogenic factor-1, in a dose-dependent manner. J. Clin. Endocrinol. Metab. 87:2002;1829-1833.
3. Altman J., Bayer S.A. The development of the rat hypothalamus. Adv. Anat. Embryol. Cell Biol. 100:1986;1-178.
4. Babu P.S., Bavers D.L., Beuschlein F., Shah S., Jeffs B., Jameson J.L., Hammer G.D. Interaction between Dax-1 and steroidogenic factor-1 in vivo increased adrenal responsiveness to ACTH in the absence of Dax-1 . Endocrinology. 143:2002;665-673.
5. Bennett J.L., Zeiler S.R., Jones K.R. Patterned expression of BDNF and NT-3 in the retina and anterior segment of the developing mammalian eye. Invest. Ophthalmol. Vis. Sci. 40:1999;2996-3005.
6. Biason-Lauber A., Schoenle E.J. Apparently normal ovarian differentiation in a prepubertal girl with transcriptionally inactive steroidogenic factor 1 (NR5A1/SF-1) and adrenocortical insufficiency. Am. J. Hum. Genet. 67:2000;1563-1568.
7. Bland M.L., Jamieson C.A., Akana S.F., Bornstein S.R., Eisenhofer G., Dallman M.F., Ingraham H.A. Haploinsufficiency of steroidogenic factor-1 in mice disrupts adrenal development leading to an impaired stress response. Proc. Natl. Acad. Sci. USA. 97:2000;14488-14493.
8. Canteras N.S. The medial hypothalamic defensive system hodological organization and functional implications . Pharmacol. Biochem. Behav. 71:2002;481-491.
9. Canteras N.S., Simerly R.B., Swanson L.W. Organization of projections from the ventromedial nucleus of the hypothalamus a Phaseolus vulgaris-leucoagglutinin study in the rat . J. Comp. Neurol. 348:1994;41-79.
10. Chateau D., Chabli A., Aron C. Effects of ventromedial nucleus lesions on the display of lordosis behavior in the male rat. Interactions with facilitory effects of male urine. Physiol. Behav. 39:1987;341-345.
11. Choi S., Dallman M.F. Hypothalamic obesity multiple routes mediated by loss of function in medial cell groups . Endocrinology. 140:1999;4081-4088.
12. Choi S., Wong L.S., Yamat C., Dallman M.F. Hypothalamic ventromedial nuclei amplify circadian rhythms do they contain a food-entrained endogenous oscillator? J. Neurosci. 18:1998;3843-3852.
13. Chu K., Zingg H.H. Activation of the mouse oxytocin promoter by the orphan receptor RORalpha. J. Mol. Endocrinol. 23:1999;337-346.
14. Cohen R.S., Pfaff D.W. Ventromedial hypothalamic neurons in the mediation of long-lasting effects of estrogen on lordosis behavior. Prog. Neurobiol. 38:1992;423-453.
15. Dellovade T.L., Young M., Ross E.P., Henderson R., Caron K., Parker K., Tobet S.A. Disruption of the gene encoding SF-1 alters the distribution of hypothalamic neuronal phenotypes. J. Comp. Neurol. 423:2000;579-589.
16. Desclozeaux, M., Krylova, I.N., Horn, F., Fletterick. R.J., Ingraham. H.A., 2002. Phosphorylation and intramolecular stabilization of the ligand binding domain in the nuclear receptor steroidosenic factor 1. Mol. Cell. Biol. 22, 7193-7203.
17. Dussault I., Fawcett D., Matthyssen A., Bader J.A., Giguere V. Orphan nuclear receptor ROR alpha-deficient mice display the cerebellar defects of staggerer. Mech. Dev. 70:1998;147-153.
18. Egawa M., Inoue S., Sato S., Takamura Y., Murakami N., Takahashi K. Restoration of circadian corticosterone rhythm in ventromedial hypothalamic lesioned rats. Neuroendocrinology. 53:1991;543-548.
19. Erskine L., Williams S.E., Brose K., Kidd T., Rachel R.A., Goodman C.S., Tessier-Lavigne M., Mason C.A. Retinal ganglion cell axon guidance in the mouse optic chiasm expression and function of robos and slits . J. Neurosci. 20:2000;4975-4982.
20. Flier J.S., Maratos-Flier E. Obesity and the hypothalamus novel peptides for new pathways . Cell. 92:1998;437-440.
21. Gavrieli Y., Sherman Y., Ben-Sasson S.A. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol. 119:1992;493-501.
22. Guan X.M., Yu H., Palyha O.C., McKee K.K., Feighner S.D., Sirinathsinghji D.J., Smith R.G., Van der Ploeg L.H., Howard A.D. Distribution of mRNA encoding the growth hormone secretagogue receptor in brain and peripheral tissues. Brain Res. Mol. Brain Res. 48:1997;23-29.
23. Hammer G.D., Ingraham H.A. Steroidogenic factor-1 its role in endocrine organ development and differentiation . Front. Neuroendocrinol. 20:1999;199-223.
24. Ikeda Y., Luo X., Abbud R., Nilson J.H., Parker K.L. The nuclear receptor steroidogenic factor 1 is essential for the formation of the ventromedial hypothalamic nucleus. Mol. Endocrinol. 9:1995;478-486.
25. Ingraham H.A., Lala D.S., Ikeda Y., Luo X., Shen W.H., Nachtigal M.W., Abbud R., Nilson J.H., Parker K.L. The nuclear receptor steroidogenic factor 1 acts at multiple levels of the reproductive axis. Genes Dev. 8:1994;2302-2312.
26. Ito M., Park Y., Weck J., Mayo K.E., Jameson J.L. Synergistic activation of the inhibin alpha-promoter by steroidogenic factor-1 and cyclic adenosine 3′,5′-monophosphate. Mol. Endocrinol. 14:2000;66-81.
27. Jones K.R., Farinas I., Backus C., Reichardt L.F. Targeted disruption of the BDNF gene perturbs brain and sensory neuron development but not motor neuron development. Cell. 76:1994;989-999.
28. Kernie S.G., Liebl D.J., Parada L.F. BDNF regulates eating behavior and locomotor activity in mice. EMBO J. 19:2000;1290-1300.
29. Kimura S., Hara Y., Pineau T., Fernandez-Salguero P., Fox C.H., Ward J.M., Gonzalez F.J. The T/ebp null mouse thyroid-specific enhancer-binding protein is essential for the organogenesis of the thyroid, lung, ventral forebrain, and pituitary . Genes Dev. 10:1996;60-69.
30. Kleyn P.W., Fan W., Kovats S.G., Lee J.J., Pulido J.C., Wu Y., Berkemeier L.R., Misumi D.J., Holmgren L., Charlat O., et al. Identification and characterization of the mouse obesity gene tubby a member of a novel gene family . Cell. 85:1996;281-290.
31. Krylova I., Zhang Y., Darimont B.D., Simpson K., Weigel N.L., Ingraham H.A. Phosphorylation of the nuclear receptor SF-1 modulates cofactor recruitment: integration of hormone signaling in reproduction and stress . Mol. Cell. 3:1999;521-526.
32. Le W., Conneely O.M., Zou L., He Y., Saucedo-Cardenas O., Jankovic J., Mosier D.R., Appel S.H. Selective agenesis of mesencephalic dopaminergic neurons in Nurr1-deficient mice. Exp. Neurol. 159:1999;451-458.
33. Liu, Q.-R., Walther, D., Uhl, G.R., 2001. Human BDNF gene: variation, expression and haplotypes associated with altered substance abuse vulnerability, Molecular Neurobiology Branch, NIDA-IRP, NIH, 5500 Nathan Shock Drive, Baltimore, MD 21224, USA.
34. Luiten P.G., ter Horst G.J., Steffens A.B. The hypothalamus, intrinsic connections and outflow pathways to the endocrine system in relation to the control of feeding and metabolism. Prog. Neurobiol. 28:1987;1-54.
35. Luo X., Ikeda Y., Parker K.L. A cell-specific nuclear receptor is essential for adrenal and gonadal development and sexual differentiation. Cell. 77:1994;481-490.
36. Majdic G., Young M., Gomez-Sanchez E., Anderson P., Szczepaniak L.S., Dobbins R.L., McGarry J.D., Parker K.L. Knockout mice lacking steroidogenic factor 1 are a novel genetic model of hypothalamic obesity. Endocrinology. 143:2002;607-614.
37. Mangelsdorf D.J., Thummel C., Beato M., Herrlich P., Schutz G., Umesono K., Blumberg B., Kastner P., Mark M., Chambon P., et al. The nuclear receptor superfamily the second decade . Cell. 83:1995;835-839.
38. Marin O., Baker J., Puelles L., Rubenstein J.L. Patterning of the basal telencephalon and hypothalamus is essential for guidance of cortical projections. Development. 129:2002;761-773.
39. Mercer J.G., Hoggard N., Williams L.M., Lawrence C.B., Hannah L.T., Trayhurn P. Localization of leptin receptor mRNA and the long form splice variant (Ob-Rb) in mouse hypothalamus and adjacent brain regions by in situ hybridization. FEBS Lett. 387:1996;113-116.
40. Michaud J.L. The developmental program of the hypothalamus and its disorders. Clin. Genet. 60:2001;255-263.
41. Michaud J.L., Rosenquist T., May N.R., Fan C.M. Development of neuroendocrine lineages requires the bHLH-PAS transcription factor SIM1. Genes Dev. 12:1998;3264-3275.
42. Nakayama M., Gahara Y., Kitamura T., Ohara O. Distinctive four promoters collectively direct expression of brain-derived neurotrophic factor gene. Brain Res. Mol. Brain Res. 21:1994;206-218.
43. Parker K.L. The roles of steroidogenic factor 1 in endocrine development and function. Mol. Cell. Endocrinol. 140:1998;59-63.
44. Pellier V., Astic L. Cell death in the developing olfactory epithelium of rat embryos. Brain Res. Dev. Brain Res. 79:1994;307-315.
45. Rios M., Fan G., Fekete C., Kelly J., Bates B., Kuehn R., Lechan R.M., Jaenisch R. Conditional deletion of brain-derived neurotrophic factor in the postnatal brain leads to obesity and hyperactivity. Mol. Endocrinol. 15:2001;1748-1757.
46. Roberts L.M., Shen J., Ingraham H.A. New solutions to an ancient riddle defining the differences between Adam and Eve . Am. J. Hum. Genet. 65:1999;933-942.
47. Sadovsky Y., Crawford P.A., Woodson K.G., Polish J.A., Clements M.A., Tourtellotte L.M., Simburger K., Milbrandt J. Mice deficient in the orphan receptor steroidogenic factor 1 lack adrenal glands and gonads but express P450 side-chain-cleavage enzyme in the placenta and have normal embryonic serum levels of corticosteroids. Proc. Natl. Acad. Sci. USA. 92:1995;10939-10943.
48. Saucedo-Cardenas O., Quintana-Hau J.D., Le W.D., Smidt M.P., Cox J.J., De Mayo F., Burbach J.P., Conneely O.M. Nurr1 is essential for the induction of the dopaminergic phenotype and the survival of ventral mesencephalic late dopaminergic precursor neurons. Proc. Natl. Acad. Sci. USA. 95:1998;4013-4018.
49. Schwartz P.M., Borghesani P.R., Levy R.L., Pomeroy S.L., Segal R.A. Abnormal cerebellar development and foliation in BDNF-/- mice reveals a role for neurotrophins in CNS patterning. Neuron. 19:1997;269-281.
50. Shimada M., Nakamura T. Time of neuron origin in mouse hypothalamic nuclei. Exp. Neurol. 41:1973;163-173.
51. Shinoda K., Lei H., Yoshii H., Nomura M., Nagano M., Shiba H., Sasaki H., Osawa Y., Ninomiya Y., Niwa O., et al. Developmental defects of the ventromedial hypothalamic nucleus and pituitary gonadotroph in the Ftz-F1 disrupted mice. Dev Dyn. 204:1995;22-29.
52. Sussel L., Marin O., Kimura S., Rubenstein J.L. Loss of Nkx2.1 homeobox gene function results in a ventral to dorsal molecular respecification within the basal telencephalon evidence for a transformation of the pallidum into the striatum . Development. 126:1999;3359-3370.
53. Swanson L.W. The Hypothalamus. 1987;Elsevier Science Publishers B.V, Amsterdam, New York, Oxford.
54. Timmusk T., Palm K., Metsis M., Reintam T., Paalme V., Saarma M., Persson H. Multiple promoters direct tissue-specific expression of the rat BDNF gene. Neuron. 10:1993;475-489.
55. Vogel M.W., Sinclair M., Qiu D., Fan H. Purkinje cell fate in staggerer mutants agenesis versus cell death . J. Neurobiol. 42:2000;323-337.
56. Voyron S., Giacobini P., Tarozzo G., Cappello P., Perroteau I., Fasolo A. Apoptosis in the development of the mouse olfactory epithelium. Brain Res. Dev. Brain Res. 115:1999;49-55.
57. Wallen A., Zetterstrom R.H., Solomin L., Arvidsson M., Olson L., Perlmann T. Fate of mesencephalic AHD2-expressing dopamine progenitor cells in NURR1 mutant mice. Exp. Cell Res. 253:1999;737-746.
58. Wren A.M., Small C.J., Ward H.L., Murphy K.G., Dakin C.L., Taheri S., Kennedy A.R., Roberts G.H., Morgan D.G., Ghatei M.A., et al. The novel hypothalamic peptide ghrelin stimulates food intake and growth hormone secretion. Endocrinology. 141:2000;4325-4328.
59. Zetterstrom R.H., Solomin L., Jansson L., Hoffer B.J., Olson L., Perlmann T. Dopamine neuron agenesis in Nurr1-deficient mice. Science. 276:1997;248-250.
60. Zhou C., Tsai S.Y., Tsai M.J. COUP-TFI an intrinsic factor for early regionalization of the neocortex . Genes Dev. 15:2001;2054-2059.